{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:50:03Z","timestamp":1792504203129,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T00:00:00Z","timestamp":1522627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00109-018-1633-x","type":"journal-article","created":{"date-parts":[[2018,4,2]],"date-time":"2018-04-02T16:58:26Z","timestamp":1522688306000},"page":"459-467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["COMP-angiopoietin-1 ameliorates inflammation-induced lymphangiogenesis in dextran sulfate sodium (DSS)-induced colitis model"],"prefix":"10.1007","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2685-1826","authenticated-orcid":false,"given":"Ae Sin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Jeong","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jin","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,2]]},"reference":[{"key":"1633_CR1","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Sandborn WJ (2007) Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369:1641\u20131657","journal-title":"Lancet"},{"key":"1633_CR2","doi-asserted-by":"publisher","unstructured":"Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M (2014) Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. \n                    https:\/\/doi.org\/10.1002\/0471142735.im1525s104","DOI":"10.1002\/0471142735.im1525s104"},{"key":"1633_CR3","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1172\/JCI71607","volume":"124","author":"H Kim","year":"2014","unstructured":"Kim H, Kataru RP, Koh GY (2014) Inflammation-associated lymphangiogenesis: a double-edged sword? J Clin Invest 124:936\u2013942","journal-title":"J Clin Invest"},{"key":"1633_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1365-2036.2011.04759.x","volume":"34","author":"JF Rahier","year":"2011","unstructured":"Rahier JF, De Beauce S, Dubuquoy L, Erdual E, Colombel JF, Jouret-Mourin A, Geboes K, Desreumaux P (2011) Increased lymphatic vessel density and lymphangiogenesis in inflammatory bowel disease. Aliment Pharmacol Ther 34:533\u2013543","journal-title":"Aliment Pharmacol Ther"},{"key":"1633_CR5","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1136\/gut.2006.114314","volume":"56","author":"S Danese","year":"2007","unstructured":"Danese S, Sans M, Spencer DM, Beck I, Donate F, Plunkett ML, de la Motte C, Redline R, Shaw DE, Levine AD, Mazar AP, Fiocchi C (2007) Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 56:855\u2013862","journal-title":"Gut"},{"key":"1633_CR6","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","volume":"87","author":"S Davis","year":"1996","unstructured":"Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC et al (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161\u20131169","journal-title":"Cell"},{"key":"1633_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/35025215","volume":"407","author":"GD Yancopoulos","year":"2000","unstructured":"Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular-specific growth factors and blood vessel formation. Nature 407:242\u2013248","journal-title":"Nature"},{"key":"1633_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1161\/01.RES.87.7.603","volume":"87","author":"JR Gamble","year":"2000","unstructured":"Gamble JR, Drew J, Trezise L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas MA (2000) Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions. Circ Res 87:603\u2013607","journal-title":"Circ Res"},{"key":"1633_CR9","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1073\/pnas.0307574101","volume":"101","author":"CH Cho","year":"2004","unstructured":"Cho CH, Kammerer RA, Lee HJ, Steinmetz MO, Ryu YS, Lee SH, Yasunaga K, Kim KT, Kim I, Choi HH et al (2004) COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A 101:5547\u20135552","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1633_CR10","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1073\/pnas.0506352103","volume":"103","author":"CH Cho","year":"2006","unstructured":"Cho CH, Sung HK, Kim KT, Cheon HG, Oh GT, Hong HJ, Yoo OJ, Koh GY (2006) COMP-angiopoietin-1 promotes wound healing through enhanced angiogenesis, lymphangiogenesis, and blood flow in a diabetic mouse model. Proc Natl Acad Sci U S A 103:4946\u20134951","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1633_CR11","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ibd.21410","volume":"17","author":"KA Oikonomou","year":"2011","unstructured":"Oikonomou KA, Kapsoritakis AN, Kapsoritaki AI, Manolakis AC, Tiaka EK, Tsiopoulos FD, Tsiompanidis IA, Potamianos SP (2011) Angiogenin, angiopoietin-1, angiopoietin-2, and endostatin serum levels in inflammatory bowel disease. Inflamm Bowel Dis 17:963\u2013970","journal-title":"Inflamm Bowel Dis"},{"key":"1633_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.crohns.2013.06.013","volume":"8","author":"PM Linares","year":"2014","unstructured":"Linares PM, Chaparro M, Gisbert JP (2014) Angiopoietins in inflammation and their implication in the development of inflammatory bowel disease. A review. J Crohn's Colitis 8:183\u2013190","journal-title":"J Crohn's Colitis"},{"key":"1633_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cellimm.2014.03.012","volume":"291","author":"CC Bain","year":"2014","unstructured":"Bain CC, Mowat AM (2014) The monocyte-macrophage axis in the intestine. Cell Immunol 291:41\u201348","journal-title":"Cell Immunol"},{"key":"1633_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/mi.2012.89","volume":"6","author":"CC Bain","year":"2013","unstructured":"Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O, Guilliams M, Malissen B, Agace WW, Mowat AM (2013) Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol 6:498\u2013510","journal-title":"Mucosal Immunol"},{"key":"1633_CR15","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8:958\u2013969","journal-title":"Nat Rev Immunol"},{"key":"1633_CR16","doi-asserted-by":"publisher","first-page":"e78128","DOI":"10.1371\/journal.pone.0078128","volume":"8","author":"J Cosin-Roger","year":"2013","unstructured":"Cosin-Roger J, Ortiz-Masia D, Calatayud S, Hernandez C, Alvarez A, Hinojosa J, Esplugues JV, Barrachina MD (2013) M2 macrophages activate WNT signaling pathway in epithelial cells: relevance in ulcerative colitis. PLoS One 8:e78128","journal-title":"PLoS One"},{"key":"1633_CR17","first-page":"99","volume":"223","author":"LA Dieleman","year":"1997","unstructured":"Dieleman LA, Pena AS, Meuwissen SG, van Rees EP (1997) Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl 223:99\u2013104","journal-title":"Scand J Gastroenterol Suppl"},{"key":"1633_CR18","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.freeradbiomed.2003.09.016","volume":"35","author":"M Sasaki","year":"2003","unstructured":"Sasaki M, Bharwani S, Jordan P, Elrod JW, Grisham MB, Jackson TH, Lefer DJ, Alexander JS (2003) Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic Biol Med 35:1679\u20131687","journal-title":"Free Radic Biol Med"},{"key":"1633_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1476-9255-2-13","volume":"2","author":"M Sasaki","year":"2005","unstructured":"Sasaki M, Mathis JM, Jennings MH, Jordan P, Wang Y, Ando T, Joh T, Alexander JS (2005) Reversal of experimental colitis disease activity in mice following administration of an adenoviral IL-10 vector. J Inflamm 2:13","journal-title":"J Inflamm"},{"key":"1633_CR20","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/intimm\/dxn033","volume":"20","author":"J Horino","year":"2008","unstructured":"Horino J, Fujimoto M, Terabe F, Serada S, Takahashi T, Soma Y, Tanaka K, Chinen T, Yoshimura A, Nomura S et al (2008) Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice. Int Immunol 20:753\u2013762","journal-title":"Int Immunol"},{"key":"1633_CR21","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/BF01303184","volume":"38","author":"SN Murthy","year":"1993","unstructured":"Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ (1993) Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 38:1722\u20131734","journal-title":"Dig Dis Sci"},{"key":"1633_CR22","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/ibd.21554","volume":"17","author":"PM Linares","year":"2011","unstructured":"Linares PM, Gisbert JP (2011) Role of growth factors in the development of lymphangiogenesis driven by inflammatory bowel disease: a review. Inflamm Bowel Dis 17:1814\u20131821","journal-title":"Inflamm Bowel Dis"},{"key":"1633_CR23","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/sj.jid.5700464","volume":"126","author":"LN Cueni","year":"2006","unstructured":"Cueni LN, Detmar M (2006) New insights into the molecular control of the lymphatic vascular system and its role in disease. J Investig Dermatol 126:2167\u20132177","journal-title":"J Investig Dermatol"},{"key":"1633_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1182\/blood-2008-12-196840","volume":"115","author":"MJ Flister","year":"2010","unstructured":"Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, Pepper MS, Zawieja DC, Ran S (2010) Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood 115:418\u2013429","journal-title":"Blood"},{"key":"1633_CR25","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1172\/JCI72189","volume":"124","author":"S D'Alessio","year":"2014","unstructured":"D'Alessio S, Correale C, Tacconi C, Gandelli A, Pietrogrande G, Vetrano S, Genua M, Arena V, Spinelli A, Peyrin-Biroulet L et al (2014) VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J Clin Invest 124:3863\u20133878","journal-title":"J Clin Invest"},{"key":"1633_CR26","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/nm.2545","volume":"17","author":"K Alitalo","year":"2011","unstructured":"Alitalo K (2011) The lymphatic vasculature in disease. Nat Med 17:1371\u20131380","journal-title":"Nat Med"},{"key":"1633_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.4110\/in.2014.14.4.182","volume":"14","author":"K Shin","year":"2014","unstructured":"Shin K, Lee SH (2014) Interplay between inflammatory responses and lymphatic vessels. Immune Netw 14:182\u2013186","journal-title":"Immune Netw"},{"key":"1633_CR28","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2353\/ajpath.2009.090133","volume":"175","author":"KE Kim","year":"2009","unstructured":"Kim KE, Koh YJ, Jeon BH, Jang C, Han J, Kataru RP, Schwendener RA, Kim JM, Koh GY (2009) Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm. Am J Pathol 175:1733\u20131745","journal-title":"Am J Pathol"},{"key":"1633_CR29","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1097\/MIB.0000000000000731","volume":"22","author":"F Becker","year":"2016","unstructured":"Becker F, Kurmaeva E, Gavins FN, Stevenson EV, Navratil AR, Jin L, Tsunoda I, Orr AW, Alexander JS, Ostanin DV (2016) A critical role for monocytes\/macrophages during intestinal inflammation-associated lymphangiogenesis. Inflamm Bowel Dis 22:1326\u20131345","journal-title":"Inflamm Bowel Dis"},{"key":"1633_CR30","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.1182\/blood-2008-09-176776","volume":"113","author":"RP Kataru","year":"2009","unstructured":"Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE, Han SH, Alitalo K, Koh GY (2009) Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 113:5650\u20135659","journal-title":"Blood"},{"key":"1633_CR31","doi-asserted-by":"publisher","first-page":"F952","DOI":"10.1152\/ajprenal.00064.2009","volume":"297","author":"YJ Jung","year":"2009","unstructured":"Jung YJ, Kim DH, Lee AS, Lee S, Kang KP, Lee SY, Jang KY, Sung MJ, Park SK, Kim W (2009) Peritubular capillary preservation with COMP-angiopoietin-1 decreases ischemia-reperfusion-induced acute kidney injury. Am J Physiol Renal Physiol 297:F952\u2013F960","journal-title":"Am J Physiol Renal Physiol"},{"key":"1633_CR32","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.imbio.2010.05.025","volume":"215","author":"WK Wu","year":"2010","unstructured":"Wu WK, Llewellyn OP, Bates DO, Nicholson LB, Dick AD (2010) IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia. Immunobiology 215:796\u2013803","journal-title":"Immunobiology"},{"key":"1633_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/ki.2012.312","volume":"83","author":"AS Lee","year":"2013","unstructured":"Lee AS, Lee JE, Jung YJ, Kim DH, Kang KP, Lee S, Park SK, Lee SY, Kang MJ, Moon WS et al (2013) Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction. Kidney Int 83:50\u201362","journal-title":"Kidney Int"},{"key":"1633_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.coi.2009.06.003","volume":"21","author":"GW Sewell","year":"2009","unstructured":"Sewell GW, Marks DJ, Segal AW (2009) The immunopathogenesis of Crohn\u2019s disease: a three-stage model. Curr Opin Immunol 21:506\u2013513","journal-title":"Curr Opin Immunol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-018-1633-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1633-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1633-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T19:09:49Z","timestamp":1554145789000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-018-1633-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,2]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1633"],"URL":"https:\/\/doi.org\/10.1007\/s00109-018-1633-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,2]]},"assertion":[{"value":"25 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal studies were reviewed and approved by the Institutional Animal Care and Use Committee of Chonbuk National University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}